CPT® Code 83008

Deleted

1. Indications

The laboratory test for cyclic guanosine monophosphate (cGMP) is indicated for several clinical scenarios, particularly in the assessment of cardiovascular health and potential complications. The following conditions may warrant the measurement of cGMP levels:

• Asymptomatic Left Ventricular Dysfunction Elevated cGMP levels have been noted in patients who exhibit asymptomatic left ventricular dysfunction, which may indicate underlying cardiac issues that require further evaluation.
• Class 1 Heart Failure The test is also relevant for patients diagnosed with class 1 heart failure, especially after exercise, as increased cGMP levels can provide insights into the heart's functional status and response to physical stress.
• Intra-Amniotic Infection Measurement of cGMP in amniotic fluid can be significant in cases of suspected intra-amniotic infection, aiding in the diagnosis and management of potential complications during pregnancy.

2. Procedure

The procedure for measuring cyclic guanosine monophosphate (cGMP) levels involves several key steps to ensure accurate and reliable results. The following outlines the procedural steps:

• Step 1: Sample Collection A blood sample is typically drawn from the patient, usually via venipuncture. The sample must be collected in a manner that prevents contamination and degradation of the cGMP present in the plasma.
• Step 2: Sample Preparation Once collected, the blood sample is processed to separate the plasma from the cellular components. This is usually achieved through centrifugation, which allows for the isolation of the plasma where cGMP is measured.
• Step 3: cGMP Measurement The prepared plasma sample is then subjected to a specific assay designed to quantify the levels of cGMP. This may involve various biochemical techniques, such as enzyme-linked immunosorbent assay (ELISA) or other analytical methods that provide precise measurements of cGMP concentrations.
• Step 4: Result Interpretation After the assay is completed, the results are analyzed and interpreted by qualified laboratory personnel. The findings are then reported to the requesting physician, who will use the information to guide clinical decision-making.

3. Post-Procedure

Post-procedure care for patients undergoing cGMP testing is generally minimal, as the test involves a standard blood draw. Patients may experience slight discomfort or bruising at the venipuncture site, which typically resolves quickly. There are no specific restrictions or extensive recovery protocols following the test. However, it is essential for healthcare providers to communicate the results to the patient and discuss any necessary follow-up actions based on the findings, particularly if elevated cGMP levels indicate potential cardiovascular issues or other medical conditions that require further investigation or management.